FDA Inspection 797574 — New York Blood Center Enterprises

New York Blood Center Enterprises — FEI 3005680856

The FDA completed an inspection of New York Blood Center Enterprises on September 5, 2012 in Port Jefferson Station, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 5, 2012
Fiscal Year
2012
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Port Jefferson Station, NY (United States)